Associations of Polypharmacy and Anticholinergic Burden With Inflammation Among US Older Adults: A Population-Based Study

July 6, 2026
JAMDA

Polypharmacy and anticholinergic burden (AB) are highly prevalent among older adults and have been linked to adverse health outcomes. However, their associations with systemic inflammation remain insufficiently characterized.